Davenport & CO LLC Axsome Therapeutics, Inc. Transaction History

Davenport & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$69.39 - $97.64 $138,780 - $195,280	2,000 Added 52.4%	5,817 $464,000
Q4 2023 Jan 23, 2024	BUY	$57.42 - $83.61 $219,172 - $319,139	3,817 New	3,817 $303,000
Q4 2022 Jan 20, 2023	BUY	$39.94 - $79.72 $567,148 - $1.13 Million	14,200 New	14,200 $0
Q1 2020 May 05, 2020	SELL	$41.2 - $101.31 $94,760 - $233,013	-2,300 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$16.71 - $106.24 $38,433 - $244,352	2,300 New	2,300 $238,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.